• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生活质量测量在多发性硬化症研究中的应用。

The use of quality of life measures in multiple sclerosis research.

作者信息

Nortvedt M W, Riise T

机构信息

Department of Public Health and Primary Health Care, University of Bergen, Ulriksdal 8C, N-5009 Bergen, Norway.

出版信息

Mult Scler. 2003 Feb;9(1):63-72. doi: 10.1191/1352458503ms871oa.

DOI:10.1191/1352458503ms871oa
PMID:12617271
Abstract

Quality of life research contributes knowledge essential to the health and healthcare of multiple sclerosis (MS) patients. This article reviews 83 MS studies in English that have presented data on quality of life. The studies may be classified into three categories, according to the application and the main focus: 1) evaluating the development and validity of quality of life questionnaires and clinical scales (n = 27); 2) evaluating factors that might influence the quality of life or comparing the quality of life among various groups (n = 37); and 3) using quality of life questionnaires as outcome measures in medical trials and other interventions (n = 19). The studies have shown that quality of life questionnaires more broadly measure the impact of MS than do the most frequently used measures of disease activity and effects. Using quality of life measures provides additional information in evaluating the effects of treatment and in studying the development of the disease. Such information is crucial in planning interventions for MS patients. A challenge in this field is to improve the study designs, including reaching some agreement on how to measure the quality of life.

摘要

生活质量研究为多发性硬化症(MS)患者的健康和医疗保健贡献了至关重要的知识。本文回顾了83项以英文发表的关于MS患者生活质量数据的研究。根据应用和主要关注点,这些研究可分为三类:1)评估生活质量问卷和临床量表的开发与效度(n = 27);2)评估可能影响生活质量的因素或比较不同群体的生活质量(n = 37);3)在医学试验和其他干预措施中使用生活质量问卷作为结果指标(n = 19)。研究表明,与最常用的疾病活动和影响测量方法相比,生活质量问卷能更广泛地衡量MS的影响。使用生活质量测量方法在评估治疗效果和研究疾病发展方面提供了额外信息。这些信息对于为MS患者制定干预措施至关重要。该领域的一个挑战是改进研究设计,包括就如何测量生活质量达成一些共识。

相似文献

1
The use of quality of life measures in multiple sclerosis research.生活质量测量在多发性硬化症研究中的应用。
Mult Scler. 2003 Feb;9(1):63-72. doi: 10.1191/1352458503ms871oa.
2
Recent developments in the assessment of quality of life in multiple sclerosis (MS).多发性硬化症(MS)生活质量评估的最新进展。
Mult Scler. 1999 Aug;5(4):251-9. doi: 10.1177/135245859900500410.
3
Evaluation of a MS specialist nurse programme.对一名多发性硬化症专科护士项目的评估。
Int J Nurs Stud. 2006 Nov;43(8):985-1000. doi: 10.1016/j.ijnurstu.2005.11.019. Epub 2006 Jan 18.
4
Two Multiple Sclerosis Quality-of-Life Measures: Comparison in a National Sample.两种多发性硬化症生活质量测量方法:全国样本中的比较
Can J Neurol Sci. 2015 Jan;42(1):55-63. doi: 10.1017/cjn.2014.128. Epub 2015 Jan 14.
5
Estimating a Preference-Based Index for an Eight-Dimensional Health State Classification System for Multiple Sclerosis.为多发性硬化症的八维健康状态分类系统估计一个基于偏好的指数。
Value Health. 2015 Dec;18(8):1025-36. doi: 10.1016/j.jval.2015.10.004. Epub 2015 Nov 17.
6
Patient-reported Outcome Measures in Multiple Sclerosis.多发性硬化症患者报告的结局指标
Int MS J. 2006 Nov;13(3):92-9.
7
A Quality-Adjusted Life-Year Measure for Multiple Sclerosis: Developing a Patient-Reported Health State Classification System for a Multiple Sclerosis-Specific Preference-Based Measure.一种用于多发性硬化症的质量调整生命年测量方法:为基于特定于多发性硬化症偏好的测量方法开发患者报告的健康状态分类系统。
Value Health. 2015 Dec;18(8):1016-24. doi: 10.1016/j.jval.2015.07.002. Epub 2015 Aug 20.
8
Caregivers of older persons with multiple sclerosis: determinants of health-related quality of life.老年多发性硬化症患者的照料者:健康相关生活质量的决定因素
J Neurosci Nurs. 2015 Apr;47(2):E2-E12. doi: 10.1097/JNN.0000000000000117.
9
Difference between generic and multiple sclerosis-specific quality of life instruments regarding the assessment of treatment efficacy.通用型与针对多发性硬化症的生活质量评估工具在治疗效果评估方面的差异。
J Neurol Sci. 2007 May 15;256(1-2):30-4. doi: 10.1016/j.jns.2007.01.080. Epub 2007 Mar 26.
10
[French validation of the Multiple Sclerosis International Quality of Life Questionnaire].[《国际多发性硬化症生活质量问卷》的法语版验证]
Rev Neurol (Paris). 2011 Jun-Jul;167(6-7):511-21. doi: 10.1016/j.neurol.2010.10.008. Epub 2011 Mar 21.

引用本文的文献

1
Determinants of self-perceived quality of life in mildly disabled multiple sclerosis patients: a cross-sectional study.轻度残疾多发性硬化症患者自我感知生活质量的决定因素:一项横断面研究。
J Neurol. 2024 Jun;271(6):3455-3461. doi: 10.1007/s00415-024-12244-0. Epub 2024 Mar 25.
2
Interventions to Improve Quality of Life in Multiple Sclerosis: New Opportunities and Key Talking Points.改善多发性硬化症患者生活质量的干预措施:新机遇与关键要点
Degener Neurol Neuromuscul Dis. 2023 Sep 19;13:55-68. doi: 10.2147/DNND.S395733. eCollection 2023.
3
Structural and construct validity of the Quality of Life Scale among Canadian women with histories of intimate partner violence.
加拿大有亲密伴侣暴力史的女性生活质量量表的结构和建构有效性。
Womens Health (Lond). 2022 Jan-Dec;18:17455057221125574. doi: 10.1177/17455057221125574.
4
Sleep Disturbances, Degree of Disability and the Quality of Life in Multiple Sclerosis Patients.多发性硬化症患者的睡眠障碍、残疾程度与生活质量
Int J Environ Res Public Health. 2022 Mar 10;19(6):3271. doi: 10.3390/ijerph19063271.
5
Health-Related Quality of Life in people with Multiple Sclerosis: How does this Population Compare to Population-based Norms in Different Health Domains?多发性硬化症患者的健康相关生活质量:该人群在不同健康领域与基于人群的标准相比如何?
J Patient Rep Outcomes. 2022 Feb 2;6(1):12. doi: 10.1186/s41687-022-00415-4.
6
The QOSMOS Study: Pharmacist-Led Multicentered Observational Study on Quality of Life in Multiple Sclerosis.QOSMOS研究:药师主导的关于多发性硬化症患者生活质量的多中心观察性研究。
Neurol Int. 2021 Dec 3;13(4):682-694. doi: 10.3390/neurolint13040065.
7
Viability of a MSQOL-54 general health-related quality of life score using bifactor model.使用双因子模型评估 MSQOL-54 一般健康相关生活质量评分的可行性。
Health Qual Life Outcomes. 2021 Sep 25;19(1):224. doi: 10.1186/s12955-021-01857-y.
8
Effectiveness of delayed-release dimethyl fumarate on patient-reported outcomes and clinical measures in patients with relapsing-remitting multiple sclerosis in a real-world clinical setting: PROTEC.在真实临床环境中,缓释富马酸二甲酯对复发缓解型多发性硬化症患者报告结局和临床指标的有效性:PROTEC研究。
Mult Scler J Exp Transl Clin. 2019 Dec 2;5(4):2055217319887191. doi: 10.1177/2055217319887191. eCollection 2019 Oct-Dec.
9
Clinical evaluation of dimethyl fumarate for the treatment of relapsing-remitting multiple sclerosis: efficacy, safety, patient experience and adherence.富马酸二甲酯治疗复发缓解型多发性硬化症的临床评估:疗效、安全性、患者体验及依从性
Patient Prefer Adherence. 2019 Oct 1;13:1655-1666. doi: 10.2147/PPA.S187529. eCollection 2019.
10
Outcomes of natalizumab treatment within 3 years of relapsing-remitting multiple sclerosis diagnosis: a prespecified 2-year interim analysis of STRIVE.复发缓解型多发性硬化症诊断后3年内那他珠单抗治疗的结果:STRIVE研究的一项预先设定的2年中期分析
BMC Neurol. 2019 Jun 8;19(1):116. doi: 10.1186/s12883-019-1337-z.